Physician profile
Jonathan S Chang
NPI 1346403961
$3,491.57
in general payments reported to CMS, 2019-2025
9 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $16.41 · 2021: $27.08 · 2022: $1,574 · 2023: $1,502 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,464 · Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,464.25 |
| Food and Beverage | $184.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,097.01 | 2022-2025 | Hydrus Microstent |
| Carl Zeiss Meditec, INC. | $213.73 | 2019-2022 | |
| Genentech, INC. | $51.39 | 2019 | |
| Dutch Ophthalmic, USA | $37.48 | 2023 | Eva, Combined Machine, Tissueblue |
| Abbvie INC. | $27.08 | 2021 | |
| Scilex Pharmaceuticals INC. | $17.75 | 2019 | |
| Allergan, INC. | $16.41 | 2020 | |
| Genentech USA, INC. | $16.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.